-million-euro loan agreement for the development and large-scale production of vaccines, including CureVac's vaccine candidate against COVID-19.
CureVac is the fourth partner the Commission has announced to have been talking with.
So far the Commission has signed an actual advance purchase agreement with AstraZeneca, and published "positive steps" with Sanofi-GSK and Johnson & Johnson.
( With inputs from IANS )
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor